OPTN Key Statistics, Chart & Performance
The current stock price of OPTN is 9.6 USD. In the past month the price increased by 4.69%. In the past year, price decreased by -42.34%.
OPTN Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to OPTN. When comparing the yearly performance of all stocks, OPTN is one of the better performing stocks in the market, outperforming 82.3% of all stocks.
OPTN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to OPTN. OPTN has a bad profitability rating. Also its financial health evaluation is rather negative.
OPTN Financial Highlights
Over the last trailing twelve months OPTN reported a non-GAAP Earnings per Share(EPS) of -2.73. The EPS decreased by -40% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -27.65% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
OPTN Forecast & Estimates
10 analysts have analysed OPTN and the average price target is 9.18 USD. This implies a price decrease of -4.37% is expected in the next year compared to the current price of 9.6.
For the next year, analysts expect an EPS growth of 1.39% and a revenue growth 27.03% for OPTN
OPTN Ownership
About OPTN
Company Profile
OptiNose, Inc. operates as a pharmaceutical company. The company is headquartered in Yardley, Pennsylvania and currently employs 127 full-time employees. The company went IPO on 2017-10-13. The firm's product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing its Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis). XHANCE combines the EDS with a liquid formulation of fluticasone propionate, a well-characterized, second-generation corticosteroid. XHANCE is designed to deliver medication into the high and deep regions of the nasal passages where both nasal polyps and inflamed and swollen membranes can obstruct normal sinus ventilation and drainage. The company has developed both a liquid delivery EDS and a powder delivery EDS utilizing natural functional behaviors of the upper nasal airways intended to offer better drug deposition.
Company Info
OPTINOSE INC
777 Township Line Road, Suite 300
Yardley PENNSYLVANIA 19067 US
CEO: Peter K. Miller
Employees: 128
Phone: 12673643500
OPTINOSE INC / OPTN FAQ
What does OPTN do?
OptiNose, Inc. operates as a pharmaceutical company. The company is headquartered in Yardley, Pennsylvania and currently employs 127 full-time employees. The company went IPO on 2017-10-13. The firm's product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing its Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis). XHANCE combines the EDS with a liquid formulation of fluticasone propionate, a well-characterized, second-generation corticosteroid. XHANCE is designed to deliver medication into the high and deep regions of the nasal passages where both nasal polyps and inflamed and swollen membranes can obstruct normal sinus ventilation and drainage. The company has developed both a liquid delivery EDS and a powder delivery EDS utilizing natural functional behaviors of the upper nasal airways intended to offer better drug deposition.
What is the current price of OPTN stock?
The current stock price of OPTN is 9.6 USD. The price decreased by -1.13% in the last trading session.
Does OPTINOSE INC pay dividends?
OPTN does not pay a dividend.
What is the ChartMill rating of OPTINOSE INC stock?
OPTN has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Is OPTINOSE INC (OPTN) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on OPTN.
How many employees does OPTINOSE INC have?
OPTINOSE INC (OPTN) currently has 128 employees.